Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial.

about

A nomogram to predict prognosis for gastric cancer with peritoneal dissemination

P2860

Q58804570-1C8FDF9F-7245-4E93-B9DE-5E52BB640D59

P2860

Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial.

Item

http://www.wikidata.org/entity/Q48052472

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Dose-dense biweekly docetaxel ...... tric cancer: a phase II trial.

@en

Dose-dense biweekly docetaxel ...... tric cancer: a phase II trial.

@nl

type

Item

label

Dose-dense biweekly docetaxel ...... tric cancer: a phase II trial.

@en

Dose-dense biweekly docetaxel ...... tric cancer: a phase II trial.

@nl

prefLabel

Dose-dense biweekly docetaxel ...... tric cancer: a phase II trial.

@en

Dose-dense biweekly docetaxel ...... tric cancer: a phase II trial.

@nl

P1476

Dose-dense biweekly docetaxel ...... tric cancer: a phase II trial.

@en

P2093

Donglin Ren

http://www.w3.org/2001/XMLSchema#string

Jian Xiao

http://www.w3.org/2001/XMLSchema#string

Jianping Wang

http://www.w3.org/2001/XMLSchema#string

Jiaying Gong

http://www.w3.org/2001/XMLSchema#string

Junsheng Peng

http://www.w3.org/2001/XMLSchema#string

Lei Wang

http://www.w3.org/2001/XMLSchema#string

Ping Lan

http://www.w3.org/2001/XMLSchema#string

Wenyun Li

http://www.w3.org/2001/XMLSchema#string

Yanhong Deng

http://www.w3.org/2001/XMLSchema#string

Yonghe Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial.

Bi-weekly docetaxel and 5-fluorouracil: an effective and feasible treatment for advanced gastric cancer with poor performance status.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

P2888

s12032-014-0334-8

P304

334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-014-0334-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25609007

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial.

about

P2860

P2860

Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921